作者: Deng Xiangbin , Deng Qiwen , Zheng Jinxin , Chen Zhong , Cheng Hang
DOI:
关键词:
摘要: The invention provides application of ovR2E in a curative effect HBV infection treatment. the treatment is characterized that protein combined with hIFN-alpha to promote combination ligand and hIFNA-2c, inhibition replication activity strengthened. According technical scheme, improves level, hR2a does not have strengthening regulating effects on action, can be strengthen activity, foundation laid for situation are prepared into mixture used improving treating CHB future, new approach provided CHB.